Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1662, 2008-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ruboxistaurin: reduced progression of diabetic retinopathy?
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :
Access to resources
Recommend
Lidocaine: Purtscher-like retinopathy?: case report
Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. :
Candesartan cilexetil + lisinopril superior to monotherapies?
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :
Candesartan cilexetil response in HF influenced by polymorphism?
Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. :
Losartan more cost effective than candesartan - or is it?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. :